Home LiteratureArticle Details
PMID: 12732658 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Constitutive expression of AID leads to tumorigenesis.

The Journal of experimental medicine ·Vol. 197 ·No. 9 ·2003-05-05 ·Pages 1173-81

Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T

Abstract

Genome stability is regulated by the balance between efficiencies of the repair machinery and genetic alterations such as mutations and chromosomal rearrangements. It has been postulated that deregulation of class switch recombination (CSR) and somatic hypermutation (SHM), which modify the immunoglobulin (Ig) genes in activated B cells, may be responsible for aberrant chromosomal translocations and mutations of non-Ig genes that lead to lymphocyte malignancy. However, the molecular basis for these genetic instabilities is not clearly understood. Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce both CSR and SHM in artificial substrates in fibroblasts as well as B cells. Here we show that constitutive and ubiquitous expression of AID in transgenic mice caused both T cell lymphomas and dysgenetic lesions of epithelium of respiratory bronchioles (micro-adenomas) in all individual mice. Point mutations, but not translocations, were massively introduced in expressed T cell receptor (TCR) and c-myc genes in T lymphoma cells. The results indicate that AID can mutate non-Ig genes including oncogenes, implying that aberrant AID expression could be a cause of human malignancy.

MeSH Terms
Animals Base Sequence Blotting, Southern Cell Transformation, Neoplastic Cytidine Deaminase/metabolism DNA Primers Flow Cytometry Lymphoid Tissue/pathology Mice Mice, Inbred C57BL Mice, SCID Mice, Transgenic Point Mutation Receptors, Antigen, T-Cell/genetics Reverse Transcriptase Polymerase Chain Reaction
Chemicals
DNA Primers Receptors, Antigen, T-Cell AICDA (activation-induced cytidine deaminase) Cytidine Deaminase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Okazaki Il-mi
Department of Medical Chemistry and Molecular Biology, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Hiai Hiroshi
Kakazu Naoki
Yamada Shuichi
Muramatsu Masamichi
Kinoshita Kazuo
Honjo Tasuku
References (32)
32 references, click to expand
  1. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts.
    Science. 2002 Jun 14;296(5575):2033-6 PMID: 12065838
  2. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells.
    J Biol Chem. 1999 Jun 25;274(26):18470-6 PMID: 10373455
  3. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase.
    Nature. 2002 Sep 5;419(6902):43-8 PMID: 12214226
  4. Somatic hypermutation of the AID transgene in B and non-B cells.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12304-8 PMID: 12202747
  5. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
    Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8483-7 PMID: 7667315
  6. MSH2 deficient mice are viable and susceptible to lymphoid tumours.
    Nat Genet. 1995 Sep;11(1):64-70 PMID: 7550317
  7. Somatic hypermutation.
    Curr Opin Immunol. 1995 Apr;7(2):248-54 PMID: 7546385
  8. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.
    Mol Cell. 2002 Nov;10(5):1247-53 PMID: 12453430
  9. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.
    Nature. 1983 Dec 22-1984 Jan 4;306(5945):760-5 PMID: 6419122
  10. Expression and rearrangement of the alpha, beta, and gamma chain genes of the T cell receptor in cloned murine large granular lymphocyte lines. No correlation with the cytotoxic spectrum.
    J Exp Med. 1986 Aug 1;164(2):428-42 PMID: 3723079
  11. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.
    Science. 1987 Nov 27;238(4831):1272-5 PMID: 3685977
  12. Efficient selection for high-expression transfectants with a novel eukaryotic vector.
    Gene. 1991 Dec 15;108(2):193-9 PMID: 1660837
  13. Molecular cloning of an apolipoprotein B messenger RNA editing protein.
    Science. 1993 Jun 18;260(5115):1816-9 PMID: 8511591
  14. Tumor spectrum analysis in p53-mutant mice.
    Curr Biol. 1994 Jan 1;4(1):1-7 PMID: 7922305
  15. Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences.
    Curr Top Microbiol Immunol. 1995;194:265-72 PMID: 7895498
  16. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
    Cell. 1995 Jul 28;82(2):321-30 PMID: 7628020
  17. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.
    Cell. 2000 Sep 1;102(5):553-63 PMID: 11007474
  18. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).
    Cell. 2000 Sep 1;102(5):565-75 PMID: 11007475
  19. Tumorigenesis in mice carrying a truncating Brca1 mutation.
    Genes Dev. 2001 May 15;15(10):1188-93 PMID: 11358863
  20. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
    Nature. 2001 Jul 19;412(6844):341-6 PMID: 11460166
  21. Quantitative regulation of class switch recombination by switch region transcription.
    J Exp Med. 2001 Aug 6;194(3):365-74 PMID: 11489955
  22. Mechanisms of chromosomal translocations in B cell lymphomas.
    Oncogene. 2001 Sep 10;20(40):5580-94 PMID: 11607811
  23. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
    Nature. 2002 Feb 14;415(6873):802-6 PMID: 11823785
  24. Molecular mechanism of class switch recombination: linkage with somatic hypermutation.
    Annu Rev Immunol. 2002;20:165-96 PMID: 11861601
  25. The AID enzyme induces class switch recombination in fibroblasts.
    Nature. 2002 Mar 21;416(6878):340-5 PMID: 11875397
  26. Atm-deficient mice: a paradigm of ataxia telangiectasia.
    Cell. 1996 Jul 12;86(1):159-71 PMID: 8689683
  27. Multicolour spectral karyotyping of mouse chromosomes.
    Nat Genet. 1996 Nov;14(3):312-5 PMID: 8896561
  28. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme.
    Genes Dev. 1997 Feb 1;11(3):321-33 PMID: 9030685
  29. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
    Nat Genet. 1997 Dec;17(4):423-30 PMID: 9398843
  30. Cis-acting sequences that affect somatic hypermutation of Ig genes.
    Immunol Rev. 1998 Apr;162:153-60 PMID: 9602361
  31. Genetic instabilities in human cancers.
    Nature. 1998 Dec 17;396(6712):643-9 PMID: 9872311
  32. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.
    Nature. 2002 Jul 4;418(6893):99-103 PMID: 12097915
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2003-05-05
Pages
1173-81
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193972
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com